Know
Most powerful obesity drug yet: People lost up to 25% of weight in trial
Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
More in Science & Emerging Technology
- NASA Opens 2027 Human Lander Challenge for Lunar Communications NASA
- Protests against OpenAI get increasingly creative Ars Technica
- NASA Awards Orbital Safety Analysis Support Services Contract NASA
- AMD acquires World Labs AI startup, upping the ante against Nvidia Ars Technica
- NASA Features Exploration, Science at International Space Conference NASA